AIDS & Health News
Stay updated on AIDS with press releases highlighting research, treatments, and advocacy efforts fighting HIV/AIDS. Stay informed on key developments shaping prevention and care, and explore opportunities in medical advancements and public health initiatives.
Mar 2, 2026 at 9:45 AM
Queen Latifah Headlining Spring Break Concert to Raise Funds for HIV/AIDS Awareness
FT. LAUDERDALE, Fla.--(BUSINESS WIRE)--Grammy, Emmy, Golden Globe, NAACP, SAG and Critic’s Choice award-winning and Oscar-nominated musician, actress, producer, label president, author and entrepreneur will headline AIDS Healthcare Foundation’s 21st Annual Florida AIDS Walk & Music Festival presented by AHF Pharmacy, Fed Ex and Wells Fargo at Fort Lauderdale Beach on Saturday, March 21, 2026. The annual 5k walk and concert, which recently celebrated its 20th anniversary, has raised millions...
Mar 2, 2026 at 8:30 AM
Gilead Foundation Awards $12 Million to Empower Community Health Workers and Expand HIV Prevention Initiatives Across 14 States and the District of Columbia
FOSTER CITY, Calif.--(BUSINESS WIRE)--GILEAD FOUNDATION AWARDS $12 MILLION TO EMPOWER COMMUNITY HEALTH WORKERS AND EXPAND HIV PREVENTION INITIATIVES ACROSS THE US...
Feb 27, 2026 at 6:01 PM
National Condom Month: Why Today’s Protection Is About Pleasure, Confidence and Connection, According to Sex & Relationship Expert, Dr. Deb Laino
PHILADELPHIA--(BUSINESS WIRE)--In recognition of National Condom Month, sex and relationship therapist Dr. Deb Laino is encouraging young adults to prioritize safer sex practices - not just for protection, but for the emotional and relational benefits that come with feeling secure and aligned with your partner. As conversations around consent and sexual wellness continue to evolve, Dr. Laino emphasizes that condoms are not just about prevention - they help create a shared understanding of respo...
Feb 26, 2026 at 6:39 PM
AHF Sues FL Health Dept. to Block Emergency Rule Cutting HIV Drug Access for Thousands
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--AHF Sues FL Health Dept. to Block Emergency Rule Cutting HIV Drug Access for Thousands...
Feb 26, 2026 at 5:08 PM
AHF to President Trump: Save Florida's AIDS Drug Assistance Program!
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--AHF to President Trump: Save Florida's AIDS Drug Assistance Program!...
Feb 26, 2026 at 12:50 PM
AHF Sues Florida to Block Fake Emergency Rule that Cuts AIDS Drugs to 16,000
TALLAHASSEE, Fla.--(BUSINESS WIRE)--This morning AIDS Healthcare Foundation (AHF) filed an administrative action to challenge the validity of the emergency rule enacted by the Florida Department of Health, prior to a hearing scheduled yesterday morning with State Administrative Law Judge W. David Watkins. The Florida Department of Health has invoked emergency powers designed to protect public health in order to cut 16,000 Floridians off their HIV medications. On the eve of a court hearing chall...
Feb 26, 2026 at 9:47 AM
Hip-Hop Royalty Headlining Spring Break Concert to Raise Funds for HIV/AIDS Awareness
FT. LAUDERDALE, Fla.--(BUSINESS WIRE)--Grammy, Emmy, Golden Globe, NAACP, SAG and Critic’s Choice award-winning and Oscar-nominated musician, actress, producer, label president, author and entrepreneur will headline AIDS Healthcare Foundation’s 21st Annual Florida AIDS Walk & Music Festival presented by AHF Pharmacy, Fed Ex and Wells Fargo at Fort Lauderdale Beach on Saturday, March 21, 2026. The annual 5k walk and concert, which recently celebrated its 20th anniversary, has raised millions...
Feb 25, 2026 at 2:00 PM
ViiV Healthcare reports positive 12-month data showing investigational bNAb lotivibart (N6LS) maintains high levels of viral suppression in long-acting HIV treatment regimen
LONDON--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,* today announced positive 12-month interim efficacy and tolerability data from the phase IIb EMBRACE study.1 In adults living with HIV on stable therapy, a regimen of lotivibart (N6LS), a broadly neutralising antibody, administered every four months combined with monthly intramuscular (IM) long-acting cabotegravir (CAB LA), maintained viral suppression in...
Feb 25, 2026 at 2:00 PM
ViiV Healthcare presents pipeline data for two investigational HIV treatment therapies with potential for twice-yearly dosing
LONDON--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,* today announced data from its phase 1 study of long-acting formulations of VH184, the first, third-generation integrase strand transfer inhibitor (INSTI) in development for HIV.1 Results show a single-dose injection could maintain drug levels for up to six months. In-vitro data from a separate study demonstrate improved potency and an enhanced resistance...
Feb 25, 2026 at 1:44 PM
Gilead’s Single-Tablet Regimen of Bictegravir and Lenacapavir Maintained Virological Suppression in People With HIV Who Switched Antiretroviral Therapy
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of new Phase 3 ARTISTRY-1 and ARTISTRY-2 trial data at CROI 2026 showing a treatment switch to an investigational, single-tablet combination regimen of bictegravir 75 mg/lenacapavir 50 mg (BIC/LEN) was effective in people living with HIV with virological suppression, including those switching from complex multi-tablet regimens or a global guideline-recommended single-tablet regimen. The n...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.